Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29

Xiang-Ming Xu1, Chao He, Xiao-Tong Hu

  • 1Department of Colorectal Surgery of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.

Abstract

Insights

This study demonstrates that a binary adenoviral vector system effectively delivers the Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) gene to colorectal cancer cells. Co-infection with Ad/PGK-GV16 significantly enhanced TRAIL

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Targeted gene therapy offers a promising avenue for CRC treatment.
  • Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) is a potent inducer of apoptosis.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of the TRAIL gene delivered via an adenoviral vector in the human colorectal cancer cell line HT29.
  • To assess the synergistic effect of a binary adenoviral vector system on TRAIL gene delivery and therapeutic outcomes.

Main Methods:

  • Adenoviral vectors (Ad/GT-TRAIL, Ad/GT-Bax, Ad/GT-LacZ, Ad/PGK-GV16) were constructed and amplified.
  • HT29 cells were transfected with Ad/GT-TRAIL, alone or in combination with Ad/PGK-GV16.
  • Bax gene served as a positive control, LacZ as a vector control, and PBS as a mock control.
  • Morphological changes, cell viability (MTT assay), and apoptosis (flow cytometry) were analyzed.

Main Results:

  • Adenoviral vectors achieved a titer of 1X10(10) viral particles/ml.
  • Ad/GT-TRAIL induced significant morphological changes and apoptosis in HT29 cells.
  • Co-infection with Ad/PGK-GV16 markedly enhanced therapeutic efficiency, suppressing HT29 growth by 85.2% and increasing apoptosis to 35.9% (P<0.05).

Conclusions:

  • A binary adenoviral vector system is effective for amplifying and delivering potentially toxic genes like TRAIL.
  • Ad/GT-TRAIL, when co-administered with Ad/PGK-GV16, demonstrates significantly enhanced therapeutic efficiency against HT29 colorectal cancer cells.
  • This binary system effectively induces apoptosis and inhibits the growth of HT29 cells, highlighting its therapeutic potential.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...